Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous lipid emulsion binding of bupivacaine in circulation
2010-021446-21Phase 4Completed
- Sponsor
- Per Rosenberg AB
- Start
- Aug 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of bupivacaine in drug intoxication, sponsored by Per Rosenberg AB. Primary endpoint: Plasma bupivacaine concentration over time during lipid emulsion infusion. Started Aug 2010; status: completed.
02
Drugs
bupivacaine
03
Conditions
drug intoxication
Beyond the preview
Go deeper on 2010-021446-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-021446-21.